SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, is collaborating with Synnovis, one of England’s leading pathology providers, to bring liquid …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
